FORBES-TATE for PHRMA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to Medicare Part D; issues related to the drug industry, issues related to comparative effectiveness, issues related to follow-on biologics; issues related to the Independent Payment Advisory Board; issues related to patent reform; issues related to ASP+6 and 340B; issues related to PCORI; issues related to pharmaceutical drug safety track and trace program legislation; issues related to low income subsidies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D; issues related to the drug industry, issues related to comparative effectiveness, issues related to follow-on biologics; issues related to the Independent Payment Advisory Board; issues related to patent reform; issues related to ASP+6 and 340B; issues related to PCORI; issues related to pharmaceutical drug safety track and trace program legislation; issues related to low income subsidies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Pharmacy PHA
Issues related to Medicare Part D; issues related to the drug industry, issues related to comparative effectiveness, issues related to follow-on biologics; issues related to the Independent Payment Advisory Board; issues related to patent reform; issues related to ASP+6 and 340B; issues related to PCORI; issues related to pharmaceutical drug safety track and trace program legislation; issues related to low income subsidies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.